Bio-Rad CFX Opus 96 Real-Time PCR System

The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Bio-Rad Laboratories, Inc. for a Bio-Rad CFX Opus 96 Real-Time PCR System. This system will be used for gene expression analysis, assay optimization, plate setup, data collection, statistical analysis, and graphing of results in the laboratory of Dr. Thomas Misteli. The system provides a 96-well, 5-color plus FRET, network-connected real-time PCR detection platform. • The system will support gene expression analysis, assay optimization, plate setup, data collection, statistical analysis, and graphing of results. • The system provides the sensitivity, thermal performance, temperature gradient capability, compact design, and optical precision needed for the laboratory's chromatin and cancer research workflows. • The NIH is seeking capability statements from small businesses that can demonstrate their ability to perform the requirement.